Home › Prescription medicine › Second Tokushima Factory, Otsuka Pharmaceutical…
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
Do not stop taking this without speaking to your pharmacist or doctor.
What’s wrong
Cross Contamination with Other Products
The Recall Registry rates this labelling issue — FDA Class III: unlikely to cause harm.
What to do
Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.
Who to contact: Recalling firm: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
The product
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
Details
- Units affected
- N/A
- Recall date
- April 9, 2024
- Brand
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
USA nationwide
The official notice
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine